ATE555447T1 - Kristallstruktur der polo-like-kinase 3 (plk3) und bindungstaschen dafür - Google Patents

Kristallstruktur der polo-like-kinase 3 (plk3) und bindungstaschen dafür

Info

Publication number
ATE555447T1
ATE555447T1 AT07796198T AT07796198T ATE555447T1 AT E555447 T1 ATE555447 T1 AT E555447T1 AT 07796198 T AT07796198 T AT 07796198T AT 07796198 T AT07796198 T AT 07796198T AT E555447 T1 ATE555447 T1 AT E555447T1
Authority
AT
Austria
Prior art keywords
plk3
relates
binding pockets
molecules
polo
Prior art date
Application number
AT07796198T
Other languages
English (en)
Inventor
Kieron Brown
Graham Mt Cheetham
Suzanne B Renwick
Joanna M Long
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharma filed Critical Vertex Pharma
Application granted granted Critical
Publication of ATE555447T1 publication Critical patent/ATE555447T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
    • G16B15/30—Drug targeting using structural data; Docking or binding prediction
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Theoretical Computer Science (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT07796198T 2006-06-14 2007-06-14 Kristallstruktur der polo-like-kinase 3 (plk3) und bindungstaschen dafür ATE555447T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81342706P 2006-06-14 2006-06-14
PCT/US2007/014149 WO2007146436A2 (en) 2006-06-14 2007-06-14 Crystal structure of polo-like kinase 3 (plk3) and binding pockets thereof

Publications (1)

Publication Number Publication Date
ATE555447T1 true ATE555447T1 (de) 2012-05-15

Family

ID=38832575

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07796198T ATE555447T1 (de) 2006-06-14 2007-06-14 Kristallstruktur der polo-like-kinase 3 (plk3) und bindungstaschen dafür

Country Status (4)

Country Link
US (1) US7700340B2 (de)
EP (1) EP2064322B1 (de)
AT (1) ATE555447T1 (de)
WO (1) WO2007146436A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009087196A1 (en) * 2008-01-10 2009-07-16 Janssen Pharmaceutica Nv Method for measuring plk4 activity
US11501853B2 (en) 2020-07-20 2022-11-15 Recursion Pharmaceuticals, Inc. Preemptible-based scaffold hopping

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4886646A (en) 1988-03-23 1989-12-12 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Hanging drop crystal growth apparatus and method
US5096676A (en) 1989-01-27 1992-03-17 Mcpherson Alexander Crystal growing apparatus
US5130105A (en) 1990-10-23 1992-07-14 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Protein crystal growth tray assembly
US5221410A (en) 1991-10-09 1993-06-22 Schering Corporation Crystal forming device
US5884230A (en) 1993-04-28 1999-03-16 Immunex Corporation Method and system for protein modeling
US5400741A (en) 1993-05-21 1995-03-28 Medical Foundation Of Buffalo, Inc. Device for growing crystals
US20030077681A1 (en) 2001-04-17 2003-04-24 Cogswell John P. PLK3 protein-protein interactions
EP1461758A4 (de) 2001-12-05 2005-10-05 Vertex Pharma Kristallstruktur eines mitogenaktivierten proteins, kinase-aktiviertes protein, kinase-2 und binde-pockets dafür
WO2004024759A1 (en) 2002-09-10 2004-03-25 The University Of British Columbia Methods and reagents for modulating cell proliferation
GB0226583D0 (en) * 2002-11-14 2002-12-18 Cyclacel Ltd Compounds
GB0326396D0 (en) 2003-11-12 2003-12-17 Cyclacel Ltd Method
WO2006053125A2 (en) 2004-11-12 2006-05-18 Aveo Pharmaceuticals, Inc. Gp201: methods and compositions for treating cancer
WO2008021379A2 (en) * 2006-08-17 2008-02-21 The Penn State University Increased activity and efficiency of expansin-like proteins

Also Published As

Publication number Publication date
WO2007146436A3 (en) 2008-04-17
WO2007146436A2 (en) 2007-12-21
US20080293579A1 (en) 2008-11-27
EP2064322B1 (de) 2012-04-25
EP2064322A2 (de) 2009-06-03
US7700340B2 (en) 2010-04-20

Similar Documents

Publication Publication Date Title
DE60331329D1 (de) Kristallstruktur des aurora-2 proteins und dessen bindungstaschen
WO2005105988A3 (en) Crystal structure of human jak3 kinase domain complex and binding pockets thereof
WO2002088078A3 (en) INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3β PROTEIN AND PROTEIN COMPLEXES
WO2008137834A3 (en) Crystal structure of smyd3 protein
CY1122672T1 (el) Βελτιωμενα nanobodiestm εναντι του παραγοντα νεκρωσης ογκων αλφα
WO2008128050A3 (en) Methods for identification of modulators of carm1 methyl transferase activity
DK2343320T3 (da) Anti-gitr-antistoffer og anvendelser deraf
WO2009070221A3 (en) Alignment-unit-based virtual formatting methods and devices employing the methods
EA200801621A1 (ru) Антитела, направленные на her-3, и их применение
ATE483027T1 (de) Rekombinante n-glykosylierte proteine aus prokaryontischen zellen
WO2008028977A3 (en) Serum albumin binding proteins with long half-lives
EA200601562A1 (ru) Сокристаллы госсипола и их применение
WO2007079218A3 (en) Metalloproteinase binding proteins
ATE496991T1 (de) Kristallstruktur von tak1-tab1
WO2004035604A3 (en) Spleen tyrosine kinase catalytic domain:crystal structure and binding pockets thereof
WO2005056785A3 (en) Crystal structure of interleukin-2 tyrosine kinase (itk) and binding pockets thereof
ATE555447T1 (de) Kristallstruktur der polo-like-kinase 3 (plk3) und bindungstaschen dafür
WO2003048340A3 (en) Crystal structure of mitogen-activated protein kinase-activated protein kinase 2 and binding pockets thereof
WO2008003707A3 (en) Minimized small peptides with high affinity for factor viii and factor viii-like proteins
NO20054238L (no) Inhibitorer av antigenpresentasjon ved MHC klasse II-molekyler og fremgangsmate for anvendelse av disse
ATE486127T1 (de) Wiederherstellung der aktivität von 5- enolpyruvylshikimat-3-phosphat-synthase durch fragmentkomplementierung
NO20025738D0 (no) Metode
WO2008111088A3 (en) Jasmonate based assays for identifying compounds that selectively inhibit mitochondrial bound hexokinases
WO2004023270A8 (en) Crystal structure of angiotensin-converting enzyme-related carboxypeptidase
WO2003060102A3 (en) Crystal structures of jnk-inhibitor complexes and binding pockets thereof